Author

Fabian Weiss

University of Zurich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1

Frequent Co-Authors

Andreas PlückthuniD· 3 shared Jonas KolibiusiD· 3 shared Patrick C. FreitagiD· 2 shared Anja KipariD· 1 shared Daphne Laarveld· 1 shared Dominik BrücheriD· 1 shared Felix GantenbeiniD· 1 shared Jeanette H.W. LeuseniD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

Andreas PlückthunORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Retargeted adenoviruses for local IgA and CD47 blocker production as a novel cancer therapy

Mariya Chernyavska, Karen Patricia Hartmann, Marco Jansen, Niklas Baumann, Jonas Kolibius, Dominik Brücher, Theodora Kristoforus, R.W. Peters, Lucas Huijs, Daphne Laarveld, Fabian Weiss, Renate Burger, Marta Lustig, Nadine Gimenez de Assis, Markus Schmid, , Wouter P. R. Verdurmen

This paper develops a retargeted adenovirus system to produce IgA antibodies and CD47 blockers in tumors, enhancing innate immune responses and reducing tumor volume in mice.

EMBO Molecular Medicine · Jul 7, 2026Peer-reviewedImmunology

Genome-replicating HC-AdV, a novel high-capacity adenoviral vector class featuring enhanced in situ payload expression

Jonas Kolibius, Fabian Weiss, Patrick C. Freitag, Andreas Plückthun

This paper develops a genome-replicating high-capacity adenoviral vector that enhances transgene expression without causing host cell death.

Molecular Therapy — Methods & Clinical Development · Sep 1, 2025Peer-reviewedBiochemistry

Dendritic cell targeting in lymph nodes with engineered modular adapters improves HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21

Fabian Weiss, Jonas Kolibius, Patrick C. Freitag, Felix Gantenbein, Anja Kipar, Andreas Plückthun

This paper develops a modular adapter system to target dendritic cells with adenoviral vectors, enhancing tumor vaccination by improving DC transduction and co-delivering cytokines.

Molecular Therapy Oncology · Apr 14, 2025Peer-reviewedBiochemistry